Zotefoams (LON:ZTF) had its price objective upped by Canaccord Genuity from GBX 550 ($7.60) to GBX 570 ($7.88) in a research report issued to clients and investors on Wednesday. The firm presently has a “buy” rating on the stock. Canaccord Genuity’s target price indicates a potential upside of 11.76% from the company’s previous close.
Shares of Zotefoams (LON ZTF) opened at GBX 510 ($7.05) on Wednesday. Zotefoams has a fifty-two week low of GBX 280 ($3.87) and a fifty-two week high of GBX 532 ($7.35). The stock has a market cap of $225.14 and a P/E ratio of 3,642.86.
In other Zotefoams news, insider Doug Robertson purchased 5,416 shares of the firm’s stock in a transaction on Wednesday, December 20th. The shares were acquired at an average cost of GBX 459 ($6.34) per share, for a total transaction of £24,859.44 ($34,345.73). Insiders acquired 5,483 shares of company stock worth $2,515,772 over the last quarter.
Zotefoams plc is a United Kingdom-based cellular material technology company. The Company is engaged in the manufacture and sale of cross-linked block foams. The Company’s segments include Polyolefins, High-Performance Products (HPP) and MuCell Extrusion LLC (MEL). Polyolefins foams are made from olefinic homopolymer and copolymer resin.
Receive News & Ratings for Zotefoams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zotefoams and related companies with MarketBeat.com's FREE daily email newsletter.